Pamorelin LA Injection (11.25mg) is a medication that contains Triptorelin, a synthetic analog of gonadotropin-releasing hormone (GnRH). This injectable formulation is primarily used in the treatment of hormone-sensitive conditions, such as prostate cancer and endometriosis. By modulating hormone levels, Pamorelin helps to reduce the production of testosterone in men and estrogen in women, thereby alleviating symptoms associated with these conditions. The 11.25mg dosage is designed for long-acting release, allowing for less frequent administration, typically every three months. This convenience enhances patient compliance and ensures more consistent therapeutic effects. The composition of Pamorelin includes Triptorelin as the active ingredient, along with excipients that facilitate its delivery and stability. Overall, Pamorelin LA Injection serves as an effective option for managing specific hormone-related disorders, providing both therapeutic benefits and improved quality of life for patients.